Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV

AIDS and Behavior

Volumn 18, Issue 6, 2014, Pages 1186-1197

  Moore, Raeanne C ^a,b   Fazeli, Pariya L ^a   Jeste, Dilip V ^a,b   Moore, David J ^a   Grant, Igor ^a   Woods, Steven Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Diego   (United States)

Author keywords

AIDS related dementia; Neuropsychological assessment; Successful aging; Well being

Indexed keywords

ADDICTION; ADULT; AGED; AGING; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGING; COGNITION; COGNITION DISORDERS; DEPRESSION; FEMALE; HEALTH STATUS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS;

EID: 84905593000     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0743-x     Document Type: Article

References (87)

1. Prevention CfDCa. HIV/AIDS among persons 50 and older. Atlanta: Center for Disease Control and Prevention; 2008.
2. Prevention CfDCa. HIV surveillance report. Atlanta: Center for Disease Control and Prevention; 2008.
3. Gardner ID. The effect of aging on susceptibility to infection. Rev Infect Dis. 1980;2(5):801-10.
4. Ernst T, Chang L. Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS. 2004;18(Suppl 1):S61-7.
5. Jernigan TL, Gamst AC, Archibald SL, et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry. 2005;162:1461-72.
6. Onen NF, Overton ET, Seyfried W, et al. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials. 2010;11(2):100-9.
7. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119-29.
8. Rodriguez-Penney A, Iudicello J, Riggs P, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDs. 2013;27(1):5-16.
9. Cherner M, Ellis RJ, Lazzaretto D, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS. 2004;18(Suppl 1):S27-34.
10. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology. 2004;63:822-7.
11. Sacktor N, Skolasky R, Selnes OA, et al. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol. 2007;3:203-9.
12. Woods SP, Dawson MS, Weber E, Grant I, Group HNRCH. The sementic relatedness of cue-intention pairings influences eventbased prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol. 2010;32(4):398-407.
13. Iudicello JE, Woods SP, Deutsch R, Grant I, Group HNRCH. Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol. 2012;34(5): 476-88.
14. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19-25.
15. Foley JM, Gooding AL, Thames AD, et al. Visuospatial and attentional abilities predict driving simulator performance among older HIV-infected adults. Am J Alzheimer's Dis Dement. 2013;28(2):185-94.
16. Doyle K, Weber E, Atkinson JH, Grant I, Woods SP, Group HNRPH. Aging, prospective memory, and health-related quality of life in HIV infection. AIDS Behav. 2012;16(8):2309-18.
17. Tozzi V, Balestra P, Galgani S, et al. Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retrovir. 2003;19(8):643-52.
18. Osowiecki DM, Cohen RA, Morrow KM, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS. 2000;14(10):1327-32.
19. Shimizu SM, Chow DC, Valcour V, et al. The impact of depressive symptoms on neuropsychological performance tests in HIV-infected adults: a study of the Hawaii aging with HIV cohort. World J AIDS. 2011;1(4):139-45.
20. Castellon SA, Hardy DJ, Hinkin CH, et al. Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance. J Clin Exp Neuropsychol. 2006;28(3):420-37.
21. Daffner KR. Promoting successful cognitive aging: a comprehensive review. J Alzheimers Dis. 2010;19(4):1101-22.
22. Depp CA, Harmell A, Vahia IV. Successful cognitive aging. Curr Topics Behav Neurosci. 2012;10:35-50.
23. Malaspina L, Woods SP, Moore DJ, et al. Successful cognitive aging in persons living with HIV infection. J Neurovirol. 2011;17:110-9.
24. Bassett SS, Folstein MF. Memory complaint, memory performance, and psychiatric diagnosis: a community study. J Geriatr Psychiatry Neurol. 1993;6:105-11.
25. Ponds RW, Commissaries KJ, Jolles J. Prevalence and covariates of subjective forgetfulness in a normal population in The Netherlands. Int J Aging Hum Dev. 1997;45:207-21.
26. McLaughlin SJ, Connell CM, Heeringa SG, Li LW, Roberts JS. Successful aging in the United States: prevalence estimates from a national sample of older adults. J Gerontol Ser B. 2010. doi:10. 1093/geronb/gbp101;65B(2):216-226.
27. Sattler C, Toro P, Schönknecht P, Schröder J. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res. 2012;196(1):90-5.
28. GlymourMM, Weuve J, Fay ME, Glass T, Berkman LF. Social ties and cognitive recovery after stroke: does social integration promote cognitive resilience? Neuroepidemiology. 2008;31(1):10-20.
29. Staudinger UM, Gluck J. Psychological wisdom research: commonalities and differences in a growing field. Annu Rev Psychol. 2011;62:215-41.
30. Hawkley LC, Berntson GG, Engeland CG, Marucha PT, Masi CM, Cacioppo JT. Stress, aging, and resilience: can accrued wear and tear be slowed? Can Psychol. 2005;46(3):115-25.
31. Vahia I, Thompson WK, Depp CA, Allison MA, Jeste DV. Developing a dimensional model for successful cognitive and emotional aging. Int Psychogeriatr. 2012;24(4):515-23.
32. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002;288(18):2271-81.
33. Bosma H, van Boxtel MP, Ponds RW, Houx PJ, Burdorf A, Jolles J. Mental work demands protect against cognitive impairment: MAAS prospective cohort study. Exp Aging Res. 2003;29(1): 33-45.
34. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789-99.
35. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759-78.
36. High KP, et al. HIV and Aging: State of knowledge and areas of critical need for research. A report to the NIH office of AIDS research by the HIV and aging working group. J Acquir Immune Defic Syndr. 2012;60:S1-18.
37. Moore RC, Moore DJ, Thompson WK, Vahia IV, Grant I, Jeste DV. A case-controlled study of successful aging in older adults with HIV. J Clin Psychiatry. 2013;14(5):e417-23.
38. Castro KG, Ward JW, Slutsker L, et al. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.
39. Wechsler D. Wechsler Test of Adult Reading: WTAR: Psychological Corporation; 2001.
40. Woods SP, Moran LM, Carey CL, et al. Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23:257-70.
41. McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego: Educational and Industrial Testing Service; 1981.
42. Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychiatry. 1999;55(1):76-86.
43. Hollingshead AB. Four factor index of social status. New Haven, Conn: Yale University; 1975.
44. SternY.What is cognitive reserve?Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448-60.
45. Robertson IH. A right hemisphere role in cognitive reserve. Neurobiol Aging. 2013. doi:10.1016/j.neurobiolaging.2013.11.028.
46. Morgan E, Woods SP, Smith C, Weber E, Scott JC, Grant I. Lower cognitive reserve among individuals with syndromic HIVassociated neurocognitive disorders (HAND). AIDS Behav. 2012;16(8):2279-85.
47. World Health Organization. Composite international diagnostic interview (CIDI, version 2.1). Geneva: World Health Organization; 1998.
48. Diagnostic and Statistical Manual of Mental Disorders (DSM-IVTR). 4th ed. Washington, DC: American Psychiatric Association; 2000.
49. Ware J, Sherbourne C. The MOS 26-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-83.
50. Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res. 2005;14(1):141-50.
51. Doyle YG, McKee M, Sherriff M. A model of successful ageing in British populations. Eur J Pub Health. 2012;22(1):71-6.
52. Pereda M, Ayuso-Mateos JL, Gómez Del Barrio A, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med. 2000;30(1): 205-17.
53. Basso MR, Bornstein RA. Estimated premorbid intelligence mediates neurobehavioral change in individuals with HIV across 12 months. J Clin Exp Neuropsychol. 2000;22(2):208-18.
54. Yaffe K, Fiocco AJ, Lindquist K, et al. Predictors of maintaining cognitive function in older adults: The Health ABC study. Neurology. 2009;72:2029-35.
55. Ellis RJ, Badiee J, Vaida F, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011;25(14):1747-51.
56. Becker JT, Kingsley L, Mullen J, et al. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology. 2009;73:1292-9.
57. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012;78(7):485-92.
58. Fabbiani M, Ciccarelli N, Tana M, et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med. 2013;14(3):136-44.
59. Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb Vasc Biol. 2012;32(9): 2060-7.
60. Letendre SL, Zheng JC, Kaul M, et al. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIVinfected individuals. J Neurovirol. 2011;17(1):63-9.
61. Everall IP, Trillo-Pazos G, Bell C, Mallory M, Sanders V, Masliah E. Amelioration of neurotoxic effects of HIV envelope protein gp 120 by fibroblast growth factor: a strategy for neuroprotection. J Neuropathol Exp Neurol. 2001;60(3):293-301.
62. Loftis JM, Hauser P. Prevalence of psychiatric and substance use disorder co-morbidities in patients with hepatitis C. Curr Dir Psychiatry. 2008;28:211-25.
63. Fama R, Rosenbloom MJ, Sassoon SA, Thompson MA, Pfefferbaum A, Sullivan EV. Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidity. Alcohol. Clin. Exp. Res. 2011;35:265-76.
64. Weber E, Blackstone K, Woods SP. Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev. 2013;23:81-98.
65. Barnes DE, Cauley JA, Lui LY, et al. Women who maintain optimal cognitive function in older adults. J Am Geriatr Soc. 2007;55(2):259-64.
66. Rosenbloom MJ, Sullivan EV, Sassoon SA, et al. Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated healthrelated quality of life. J Stud Alcohol Drugs. 2007;68:115-25.
67. Sassoon SA, Rosenbloom MJ, Fama R, Sullivan EV, Pfefferbaum A. Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity. Psychiatry Res. 2012;199:102-10.
68. Rourke SB, Grant I. The neurobehavioral correlates of alcoholism. In: Grant I, Adams K, editors. Neuropsychological assessment of neuropsychiatric and neuromedical disorders. New York: Oxford University Press; 2009.
69. Eom CS, Shin DW, Kim SY, et al. Impact of perceived social support on the mental health and health-related quality of life in cancer patients: results from a nationwide, multicenter survey in South Korea. Psychooncology. 2013;22(6):1289-90.
70. Patterson TL, Shaw WS, Semple SJ, et al. Relationship of psychosocial factors to HIV disease progression. Ann Behav Med. 1996;18(1):30-9.
71. Hays RD, Shapiro MF. An overview of generic health-related quality of life measures for HIV research. Qual Life Res. 1992;1(2):91-7.
72. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010;7:69-76.
73. Chan N, Anstey KJ, Windsor TD, Luszcz MA. Disability and depressive symptoms in later life: the stress-buffering role of informal and formal support. Gerontology. 2010;57(2):180-9.
74. Henry JD, Phillips LH, Ruffman T, Bailey PE. A meta-analytic review of age differences in theory of mind. Psychol Aging. 2013;28(3):826-39.
75. Lane TA, Moore DM, Batchelor J, Brew BJ, Cysique LA. Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status. Neuropsychology. 2012;26(6):713-22.
76. Manly JJ, Patterson TL, Heaton RK, et al. The relationship between neuropsychological functioning and coping activity among HIV-positive men. AIDS Behav. 1997;1(2):81-91.
77. Moore AD, Stambrook M, Peters LC. Coping strategies and adjustment after closed head-injury: a cluster analytical approach. Brain Inj. 1989;3:171-5.
78. Jeste DV, Savla GN, Thompson WK, et al. Association between older age and more successful aging: critical role of resilience and depression. Am J Psychiatry. 2013;170:188-96.
79. Kahana E, Kahana B. Successful aging among people with HIV/AIDS. J Clin Epidemiol. 2001;54:S53-6.
80. Vance DE, Bayless H, Kempf MC, Keltner NL, Fazeli PL. Augmenting the components of successful aging. Aging Health. 2011;7:435-46.
81. Vance DE, Burrage JW. Promoting successful cognitive aging in adults with HIV: strategies for intervention. J Gerontol Nurs. 2006;32(11):34-41.
82. Vance DE, Eagerton G, Harnish B, McKie P, Fazeli PL. Cognitive prescriptions. J Gerontol Nurs. 2011;37(4):22-9.
83. Richards M, Deary IJ. A life course approach to cognitive reserve: a model for cognitive aging and development? Ann Neurol. 2005;58:612-22.
84. Rabbitt P. Does it all go together when it goes? The nineteenth Bartlett Memorial Lecture. Q J Exp Psychol A. 1993;46A: 385-434.
85. Wilson RS, Barnes LL, Bennett DA. Assessment of lifetime participation in cognitively stimulating activities. In: Stern Y, editor. Cognitive reserve: theory and applications. New York, NY: Taylor and Francis; 2007. p. 159-72.
86. Schaie KW. Intellectual development in adulthood. New York, NY: Cambridge University Press; 1996.
87. Fritsch T, McClendon MJ, Smyth KA, Lerner AJ, Friedland RP, Larsen JD. Cognitive functioning in healthy aging: the role of reserve and lifestyle factors early in life. Gerontologist. 2007;47(3):307-22.